Spironolactone in the treatment of hirsutism.
Spironolactone was used in 90 hirsute women because of its antiandrogenic effect. The drug was administered twice daily from the 4th to the 22nd day of six cycles (total dosage was 200 mg per day). The results suggest that spironolactone is suitable for the treatment of hirsutism.
D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000328:Adult; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006628:Hirsutism / Q000188:drug therapy*; D006801:Humans; D013148:Spironolactone / Q000627:therapeutic use*; D013739:Testosterone / Q000097:blood
D015068:17-Ketosteroids; D013148:Spironolactone; D013739:Testosterone; D005640:Follicle Stimulating Hormone